Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Early screening and HPV vaccination reduce cervical cancer risk.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Hypochlorous acid is a safe, effective antimicrobial with potential in various medical fields, but more research is needed to improve its stability and use.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Covid-19 worsens existing health issues and long-term effects are predictable.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

COVID-19 can cause temporary hair loss due to stress and inflammation.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Enhancing antioxidant responses can improve treatments for various diseases.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Multitarget drugs are needed to better treat complex diseases.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.